nvo market cap by year

Novo Nordisk A-S (NVO) has a market capitalization of $276.2B, based on 4.45B shares at a price of $62.08 (up 2.3% yesterday).

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
April 2025
$62.08
192,785,500
4,448,540,503
$276,165,394,426.24
March 2025
$69.44
148,675,300
4,460,500,000
$309,737,120,000.00
February 2025
$89.21
167,481,000
4,460,500,000
$397,931,910,200.00
January 2025
$83.11
189,744,500
4,460,500,000
$370,715,277,350.00
December 2024
$84.66
170,270,800
4,460,500,000
$377,607,195,900.00
November 2024
$105.11
121,022,000
4,460,500,000
$468,826,651,150.00
October 2024
$110.17
108,317,800
4,460,500,000
$491,433,803,300.00
September 2024
$117.18
78,553,700
4,460,500,000
$522,688,972,850.00
August 2024
$136.95
90,131,500
4,460,500,000
$610,879,302,550.00
July 2024
$130.04
92,171,100
4,460,500,000
$580,042,973,950.00
June 2024
$139.95
69,366,700
4,465,400,000
$624,943,893,500.00
May 2024
$132.64
83,584,100
4,465,400,000
$592,282,618,280.00
April 2024
$125.80
79,140,600
4,465,400,000
$561,766,521,220.00
March 2024
$125.89
117,225,100
4,470,500,000
$562,802,421,250.00
February 2024
$116.59
105,942,800
4,470,500,000
$521,215,147,950.00
January 2024
$111.69
96,109,800
4,470,500,000
$499,325,344,700.00
December 2023
$100.70
73,608,100
4,477,400,000
$450,888,507,680.00
November 2023
$99.14
99,919,300
4,477,400,000
$443,871,526,400.00
October 2023
$94.01
113,056,200
4,477,400,000
$420,902,016,660.00
September 2023
$88.53
89,019,100
4,489,000,000
$397,390,520,600.00
August 2023
$90.35
92,845,400
4,489,000,000
$405,561,847,300.00
July 2023
$78.04
48,119,400
4,489,000,000
$350,303,604,000.00
June 2023
$78.39
52,715,800
4,502,600,000
$352,957,012,960.00
May 2023
$77.73
62,124,400
4,502,600,000
$349,969,087,600.00
April 2023
$80.94
54,888,200
4,502,600,000
$364,429,187,500.00